Results 321 to 330 of about 228,949 (361)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

MULTIMODAL THERAPY

The Lancet, 1980
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Multimodality Therapy

2019
Jung Hoon Lee, Jae Hyun Jung, Hyeong Dong Yuk   +2 more
openaire   +1 more source

Therapie des Lokalrezidivs — multimodal?

2000
Aus der Literatur ergibt sich im Median eine Lokalrezidivrate beim Mammakarzinom von 9% nach 5 Jahren. Die Problematik der Datenerfassung wird anhand der deutschen Krebsregister, von Studienergebnissen sowie fremden und eigenen Klinikregistern erlautert. Es finden sich in Beobachtungsstudien Hinweise fur den Wert einer zusatzlichen Strahlentherapie. Ob
openaire   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Photodynamic therapy of cancer: An update

Ca-A Cancer Journal for Clinicians, 2011
Patrizia M Agostinis, Kristian Berg, Keith A Cengel   +2 more
exaly  

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly